Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study
Clinical trial NCT07243418 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07243418
- Sponsor
- Fujian Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-30
- Primary completion
- 2027-11-30
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.